Pfizer's stock is poised for growth with strong technical and fundamental indicators, promising pipeline, and Seagen ...
Leerink Partners analyst David Risinger has maintained their neutral stance on PFE stock, giving a Hold rating yesterday. David Risinger has ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Lower interest rates make these stand-out dividend payers must-see investments for those who want passive income.
Consequently, Bansal believes that Pfizer’s stock should be held as it is not expected to outperform or underperform significantly in the near future. Bansal covers the Healthcare sector, focusing ...
U.S. stocks were lower, with the Dow Jones index falling more than 100 points on Monday. Shares of Pfizer Inc PFE rose during ...